Candida albicans Ab.IgM
Quantifies early immune antibodies (IgM) specific to Candida albicans fungus in your blood.
Why This Biomarker Matters
Elevated IgM indicates recent or acute Candida infection, distinguishing it from chronic exposure. This helps determine if active treatment is needed and assess whether infections are resolving.
Overview
This test measures IgM antibodies against Candida albicans, which are produced early in response to fungal infection. IgM antibodies indicate recent or acute infection, making this test useful for distinguishing new Candida infections from chronic or past exposures. Elevated IgM levels suggest your body is actively fighting a Candida infection, helping determine if antifungal treatment is needed and monitoring treatment response.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
56150-6PrimaryAvailable Lab Tests
Order tests that measure this biomarker